Oncology /Immuno-oncology Platform
Non-Human Primates Platform
Inflammation/Autoimmune Diseases Model
Metabolic/Liver/Cardiovascular Diseases Model
Subcutaneous tumor models are most frequently used to evaluate the in vivo efficacy of novel anticancer drug candidates. Tumor cells are subcutaneously implanted on the flank of animals, mostly rodents, where they proliferate and form measurable tumors.
PharmaLegacy has more than 20 tumor types and 120 tumor cell lines. The standard delivery data for the pharmacodynamic experiments of subcutaneous xenotransplantation tumor models includes animal weight, tumor growth curve (based on tumor volume), tumor weight, and tumor suppression rate. PharmaLegacy can also provide customers with animal tissue and humoral samples and related biomarkers analysis.